Tick-Borne Langat/Mosquito-Borne Dengue Flavivirus Chimera, a Candidate Live Attenuated Vaccine for Protection against Disease Caused by Members of the Tick-Borne Encephalitis Virus Complex: Evaluation in Rhesus Monkeys and in Mosquitoes
about
Kissing-loop interaction between 5' and 3' ends of tick-borne Langat virus genome 'bridges the gap' between mosquito- and tick-borne flaviviruses in mechanisms of viral RNA cyclization: applications for virus attenuation and vaccine developmentWest Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacyInhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonistEvaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteersComparative Neuropathogenesis and Neurovirulence of Attenuated Flaviviruses in Nonhuman PrimatesEvaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeysExploring of primate models of tick-borne flaviviruses infection for evaluation of vaccines and drugs efficacy.Synergistic Internal Ribosome Entry Site/MicroRNA-Based Approach for Flavivirus Attenuation and Live Vaccine Development.Silencing of neurotropic flavivirus replication in the central nervous system by combining multiple microRNA target insertions in two distinct viral genome regionsInsertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype.Chimeric tick-borne encephalitis/dengue virus is attenuated in Ixodes scapularis ticks and Aedes aegypti mosquitoes.Replacement of the 3' untranslated variable region of mosquito-borne dengue virus with that of tick-borne Langat virus does not alter vector specificity.Recent advancement in flavivirus vaccine development.Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysisTargeted mutagenesis as a rational approach to dengue virus vaccine development.Microarray hybridization for assessment of the genetic stability of chimeric West Nile/dengue 4 virusMicroRNA-based control of tick-borne flavivirus neuropathogenesis: Challenges and perspectives.The Emerging Duck Flavivirus Is Not Pathogenic for Primates and Is Highly Sensitive to Mammalian Interferon Antiviral Signaling.Macaque models of human infectious disease.Tick-borne Encephalitis Vaccines.Vaccination of volunteers with low-dose, live-attenuated, dengue viruses leads to serotype-specific immunologic and virologic profilesThe live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteers.Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates.Mosquito saliva serine protease enhances dissemination of dengue virus into the mammalian host.Substitution of the premembrane and envelope protein genes of Modoc virus with the homologous sequences of West Nile virus generates a chimeric virus that replicates in vertebrate but not mosquito cellsHost range specificity of flaviviruses: correlation with in vitro replication.A Roadmap for Tick-Borne Flavivirus Research in the "Omics" Era.
P2860
Q24289179-0DF26986-5A2A-4A37-8DA2-ACCED0B824ADQ27471660-AA9B995D-BE1B-4CAC-A099-E97D09EB267CQ27472136-A485BE9C-083E-49D7-A401-695B864A743EQ27485433-3403D153-7DDA-4F87-BAD2-04C49C4F1AEBQ27486117-FA06299D-A91D-41E8-BA2B-81015F46F434Q27487013-A9451D16-CCCC-41EA-A9C7-B87664E7AE01Q33407061-3B971272-2907-4826-8265-EABB82E05CF4Q33576050-0767A41D-0CA1-479A-B2E0-256A298E5A90Q33821694-7838D078-6B73-4EA0-9AED-5B0B77BF4449Q34529812-236AB55A-4086-415E-A88E-A92A9CE4EDECQ35046285-4631F449-8C18-461B-9D51-EA0B2EB4DBE5Q35097570-4FA59F16-B8AC-4B31-94A3-8B2080BBDA2CQ35728621-868F49CF-50ED-442D-961B-67640F3E5737Q36082908-2C86CE3F-C424-45B3-9CAF-BACC2D55761AQ36118259-D20229F3-E8E4-4515-952A-4152E2B6AF27Q36136167-1DD51AD9-B37C-4CCD-A0CB-FB834349B675Q36599056-3B9580FC-560C-47FC-B5CF-A75E6C05A65EQ37073267-C7772A4B-9237-4B2A-B94B-238101FCB595Q37103536-673333BD-D9F1-47E2-B955-F5344C1C7D63Q37127083-8BB91071-33E1-412D-8F35-94B4DBD55A92Q37184768-73BAF7A8-6A95-4BCA-BB91-2E69D85C1797Q37324444-2D8CE338-2411-4508-8EF4-B7D146134688Q37423499-0026ED02-160A-4721-B11C-A5C1B3356FABQ37547686-85F413FA-D016-41B3-91F8-774193E19BB8Q38963356-7F78874D-4CD8-4A6F-B518-4CF45054F701Q43035806-976D7EF9-18CE-47DA-A859-3667AFD9A44EQ47193184-2BCA14BA-C71C-480F-B91D-0AAE87D0BD1B
P2860
Tick-Borne Langat/Mosquito-Borne Dengue Flavivirus Chimera, a Candidate Live Attenuated Vaccine for Protection against Disease Caused by Members of the Tick-Borne Encephalitis Virus Complex: Evaluation in Rhesus Monkeys and in Mosquitoes
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Tick-Borne Langat/Mosquito-Bor ...... esus Monkeys and in Mosquitoes
@ast
Tick-Borne Langat/Mosquito-Bor ...... esus Monkeys and in Mosquitoes
@en
Tick-Borne Langat/Mosquito-Bor ...... esus Monkeys and in Mosquitoes
@nl
type
label
Tick-Borne Langat/Mosquito-Bor ...... esus Monkeys and in Mosquitoes
@ast
Tick-Borne Langat/Mosquito-Bor ...... esus Monkeys and in Mosquitoes
@en
Tick-Borne Langat/Mosquito-Bor ...... esus Monkeys and in Mosquitoes
@nl
prefLabel
Tick-Borne Langat/Mosquito-Bor ...... esus Monkeys and in Mosquitoes
@ast
Tick-Borne Langat/Mosquito-Bor ...... esus Monkeys and in Mosquitoes
@en
Tick-Borne Langat/Mosquito-Bor ...... esus Monkeys and in Mosquitoes
@nl
P2093
P2860
P1433
P1476
Tick-Borne Langat/Mosquito-Bor ...... esus Monkeys and in Mosquitoes
@en
P2093
P2860
P304
P356
10.1128/JVI.75.17.8259-8267.2001
P577
2001-09-01T00:00:00Z